Quadruple Agonist Reduced Weight Without Major Muscle Loss in… | HappeningNow.news

Health · 3 views

Quadruple Agonist Reduced Weight Without Major Muscle Loss in Mid-Stage Trial

Source Summary Published 1h 08m ago Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 3 Community interest
Brief read Under 1 min brief 31 words

Summary

(MedPage Today) -- NATIONAL HARBOR, Md. -- An investigational oral quadruple receptor agonist led to substantial weight loss with preservation of lean mass, a randomized phase II trial presented here showed.

Read original at MedPage Today

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page